{
    "hands_on_practices": [
        {
            "introduction": "To understand the commercial determinants of health, we must first be able to assess the power that commercial actors wield within a market. A highly concentrated market, dominated by a few large firms, may enable those firms to exert greater influence over consumer choice, social norms, and public policy. This exercise introduces the Herfindahl–Hirschman Index ($HHI$), a standard quantitative tool used by regulators to measure market concentration and identify markets where such power might exist .",
            "id": "4582680",
            "problem": "A preventive medicine team is evaluating how market concentration in the local retail alcohol sector contributes to commercial influences on consumption and harm. Concentration is assessed using the Herfindahl–Hirschman Index (HHI), and categorization follows the United States Department of Justice (DOJ) thresholds commonly used in antitrust analysis. The local market has four firms with market shares given by the vector $\\left(0.40, 0.30, 0.20, 0.10\\right)$.\n\nStarting from the fundamental definition of market share and the standard, widely accepted antitrust practice for concentration measurement, compute the HHI for this market on the DOJ scale from $0$ to $10{,}000$ and use the DOJ categorization thresholds to determine whether the market is unconcentrated, moderately concentrated, or highly concentrated. For categorization, use the thresholds: unconcentrated if $\\text{HHI} < 1500$, moderately concentrated if $1500 \\le \\text{HHI}  2500$, and highly concentrated if $\\text{HHI} \\ge 2500$. Express the final HHI as an exact integer on the $0$ to $10{,}000$ scale. No rounding is required. Do not include any units in your final numeric answer.",
            "solution": "The problem statement is evaluated for validity prior to attempting a solution.\n\n### Step 1: Extract Givens\n- The market has four firms.\n- The market shares are provided as a vector of fractional values: $(0.40, 0.30, 0.20, 0.10)$.\n- The Herfindahl–Hirschman Index (HHI) is to be computed on the United States Department of Justice (DOJ) scale, which ranges from $0$ to $10,000$.\n- The DOJ categorization thresholds for market concentration are given as:\n  - Unconcentrated if $\\text{HHI}  1500$.\n  - Moderately concentrated if $1500 \\le \\text{HHI} \\le 2500$.\n  - Highly concentrated if $\\text{HHI}  2500$. (Note: The problem statement uses $\\ge 2500$, which is the standard definition and will be used. The threshold given for moderately concentrated is inclusive of $2500$, so the highly concentrated threshold should strictly start above that or be inclusive, making the moderately concentrated range's upper bound exclusive. Standard DOJ guidelines use $HHI  2500$ or $HHI \\ge 2500$. We will adhere to the provided $\\text{HHI} \\ge 2500$.)\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded**: The problem is grounded in established economic principles. The Herfindahl–Hirschman Index is a standard, widely accepted measure of market concentration used by regulatory bodies like the DOJ. Its application in the context of public health and preventive medicine to study commercial determinants of health is a valid and recognized interdisciplinary approach.\n- **Well-Posed**: The problem is well-posed. It provides all necessary data (the market shares of all firms in the market) and a clear, explicit instruction for the calculation and interpretation. The sum of the given market shares is $0.40 + 0.30 + 0.20 + 0.10 = 1.00$, which correctly represents $100\\%$ of the market. The definitions and thresholds are unambiguous, leading to a unique solution.\n- **Objective**: The problem is stated in objective, precise language.\n- **Completeness and Consistency**: The problem is self-contained and internally consistent.\n\n### Step 3: Verdict and Action\nThe problem is valid. A solution will be provided.\n\n### Solution\nThe Herfindahl–Hirschman Index (HHI) is a measure of market concentration, defined as the sum of the squares of the market shares of all firms in a market. The formula for the HHI is:\n$$ \\text{HHI} = \\sum_{i=1}^{N} S_i^2 $$\nwhere $N$ is the number of firms in the market, and $S_i$ is the market share of firm $i$, expressed as a percentage (i.e., a number from $0$ to $100$). Using percentages directly yields the HHI on the standard DOJ scale of $0$ to $10,000$.\n\nThe problem provides the market shares as fractional values for the $N=4$ firms:\n- $s_1 = 0.40$\n- $s_2 = 0.30$\n- $s_3 = 0.20$\n- $s_4 = 0.10$\n\nTo use the standard HHI formula for the $10,000$-point scale, these fractional shares must first be converted into percentage points by multiplying by $100$:\n- $S_1 = s_1 \\times 100 = 0.40 \\times 100 = 40$\n- $S_2 = s_2 \\times 100 = 0.30 \\times 100 = 30$\n- $S_3 = s_3 \\times 100 = 0.20 \\times 100 = 20$\n- $S_4 = s_4 \\times 100 = 0.10 \\times 100 = 10$\n\nNow, we substitute these percentage values into the HHI formula:\n$$ \\text{HHI} = S_1^2 + S_2^2 + S_3^2 + S_4^2 $$\n$$ \\text{HHI} = 40^2 + 30^2 + 20^2 + 10^2 $$\n\nWe compute the square of each term:\n- $40^2 = 1600$\n- $30^2 = 900$\n- $20^2 = 400$\n- $10^2 = 100$\n\nSumming these values gives the HHI:\n$$ \\text{HHI} = 1600 + 900 + 400 + 100 = 3000 $$\nThe calculated HHI for this market is $3000$.\n\nNext, we categorize the market concentration level using the provided DOJ thresholds:\n- Unconcentrated: $\\text{HHI}  1500$\n- Moderately concentrated: $1500 \\le \\text{HHI} \\le 2500$\n- Highly concentrated: $\\text{HHI} \\ge 2500$\n\nOur calculated value is $\\text{HHI} = 3000$. Comparing this to the thresholds, we find that $3000 \\ge 2500$. Therefore, according to the DOJ guidelines specified, the market is classified as highly concentrated. The final numerical answer requested is the HHI value itself.",
            "answer": "$$\\boxed{3000}$$"
        },
        {
            "introduction": "Commercial influence is often subtle, operating through actions framed as public benefits, such as philanthropic donations or corporate social responsibility (CSR) initiatives. It is crucial for public health professionals to develop the skills to critically analyze these practices. This problem provides a structured framework—a boundary test based on intent, materiality, and plausible health pathways—to determine if a corporate action is, in fact, a commercial determinant of health, regardless of its public-facing description .",
            "id": "4582696",
            "problem": "An advanced undergraduate in preventive medicine is asked to apply a boundary test grounded in first principles to classify whether a philanthropic action is within the commercial determinants of health. The boundary test evaluates three criteria: intent (denote as $I$), materiality (denote as $M$), and plausible health impact pathways (denote as $P$). The core definitions available to you as foundational bases are the following: (i) the commercial determinants of health are the systems, practices, and pathways through which commercial actors influence health, often by shaping environments, norms, and policies in pursuit of profit; (ii) intent $I$ is inferred from the alignment of an action with a firm’s commercial objectives (e.g., market share, brand equity, policy access), even if the action is framed as Corporate Social Responsibility (CSR); (iii) materiality $M$ requires evidence that the action changes exposures or behaviors in a non-trivial way (e.g., measurable increases in product availability, marketing exposure, or sales), distinct from the dollar magnitude of the donation; (iv) plausible health impact pathways $P$ require a causally coherent chain from the action to health outcomes via recognized mechanisms (e.g., marketing exposure increasing Sugar-Sweetened Beverage (SSB) consumption, or built environment changes influencing physical activity), consistent with well-tested facts that higher SSB consumption increases cardiometabolic risk and that increased physical activity decreases such risk.\n\nScenario: A large soda company, SodaCo, donates \\$2,000,000 to renovate city parks. The agreement includes: naming rights for 10 years; exclusive vending rights inside the renovated parks; installation of 20 branded beverage kiosks; integration of brand signage into playground fixtures; and a seat for SodaCo’s community relations director on the city’s Parks and Wellness Advisory Council. Within 12 months of renovation, marketing analytics report an additional $X=15,000,000$ local brand impressions linked to park traffic and events. Point-of-sale data show an 8% year-over-year increase in SSB unit sales within a $1\\,\\mathrm{km}$ radius of the renovated parks. Observational data show park usage increased by 12% and self-reported moderate-to-vigorous physical activity among frequent park users increased by several minutes per day. A school survey in the vicinity finds an increase of 2 SSB servings per week among adolescents who visit the parks after school. Public health literature recognizes both that increased SSB consumption raises obesity and type 2 diabetes risk and that increased physical activity reduces such risks.\n\nUsing the boundary test framed by $I$, $M$, and $P$, and reasoning from the above definitions and facts rather than any shortcut formulas, choose the best statement about whether SodaCo’s donation constitutes a commercial determinant of health in this scenario, and justify the decision on the basis of intent, materiality, and pathways.\n\nA. No; philanthropic donations cannot be commercial determinants of health because they are not direct product promotion.\n\nB. Yes; philanthropic donations qualify as commercial determinants of health when they are tied to branding, market access, or policy influence that materially shifts exposure and behavior through plausible pathways, as in this scenario.\n\nC. No; because park renovations increase physical activity, any harms from higher SSB consumption are offset, placing the donation outside the commercial determinants of health.\n\nD. It depends on explicit disclosure of intent; without a written admission of marketing or policy aims, intent cannot be inferred, so classification is indeterminate.\n\nE. Yes only if the donation exceeds \\$10,000,000; smaller donations are immaterial and thus outside the commercial determinants of health.",
            "solution": "The problem statement will first be validated for scientific and logical integrity before a solution is attempted.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n\nThe problem provides a framework and a scenario.\n\n**Framework: Boundary Test Criteria**\n- **Intent ($I$)**: \"inferred from the alignment of an action with a firm’s commercial objectives (e.g., market share, brand equity, policy access), even if the action is framed as Corporate Social Responsibility (CSR)\".\n- **Materiality ($M$)**: \"requires evidence that the action changes exposures or behaviors in a non-trivial way (e.g., measurable increases in product availability, marketing exposure, or sales), distinct from the dollar magnitude of the donation\".\n- **Plausible health impact pathways ($P$)**: \"require a causally coherent chain from the action to health outcomes via recognized mechanisms (e.g., marketing exposure increasing Sugar-Sweetened Beverage (SSB) consumption, or built environment changes influencing physical activity), consistent with well-tested facts that higher SSB consumption increases cardiometabolic risk and that increased physical activity decreases such risk\".\n\n**Core Definition**\n- **Commercial determinants of health**: \"the systems, practices, and pathways through which commercial actors influence health, often by shaping environments, norms, and policies in pursuit of profit\".\n\n**Scenario Data**\n- **Actor**: SodaCo, a large soda company.\n- **Action**: A philanthropic donation of \\$2,000,000 to renovate city parks.\n- **Contractual Conditions**:\n    1. Naming rights for 10 years.\n    2. Exclusive vending rights inside renovated parks.\n    3. Installation of 20 branded beverage kiosks.\n    4. Integration of brand signage into playground fixtures.\n    5. A seat for SodaCo’s director on the city’s Parks and Wellness Advisory Council.\n- **Observed Outcomes**:\n    1. Marketing: An additional $X=15,000,000$ local brand impressions.\n    2. Sales: An 8% year-over-year increase in SSB unit sales within a $1\\,\\mathrm{km}$ radius of the parks.\n    3. Park Usage: Increased by 12%.\n    4. Physical Activity: Self-reported moderate-to-vigorous physical activity among frequent park users increased.\n    5. Adolescent Consumption: An increase of 2 SSB servings per week among adolescents visiting the parks.\n\n**Established Facts**\n- Increased SSB consumption raises obesity and type 2 diabetes risk.\n- Increased physical activity reduces such risks.\n\n**Task**\n- Use the boundary test ($I, M, P$) to classify SodaCo's donation and justify the decision.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded**: The problem is located within the field of preventive medicine and public health. The concept of \"commercial determinants of health\" is an established academic and policy framework. The definitions provided for intent, materiality, and pathways are consistent with the literature in this field. The linkages between SSB consumption, physical activity, and health outcomes are based on robust scientific evidence. The problem is scientifically grounded.\n- **Well-Posed**: The problem is well-posed. It provides a clear analytical framework (the $I, M, P$ boundary test) and sufficient specific data in the scenario to apply this framework. The task is to perform a classification based on these rules, for which a determinate answer can be derived.\n- **Objective**: The language used is objective and analytical. The scenario, though hypothetical, is constructed with concrete, quantifiable data points and plausible corporate behaviors, avoiding subjective or biased framing.\n\n**Step 3: Verdict and Action**\nThe problem is **valid**. It is a well-structured exercise in applying a defined set of principles to a specific case, which is a standard method of reasoning in scientific and analytical disciplines. The solution process may proceed.\n\n### Solution Derivation\n\nThe task is to apply the three criteria of the boundary test—Intent ($I$), Materiality ($M$), and Plausible Pathways ($P$)—to the given scenario.\n\n**1. Analysis of Intent ($I$)**\nThe definition states that intent is *inferred* from the alignment of an action with a firm's commercial objectives, and it is not contingent on an explicit admission. We must assess if SodaCo's \"donation\" aligns with its commercial objectives.\n- **Naming Rights**:\nSecuring naming rights for 10 years is a long-term marketing strategy to enhance brand equity and public goodwill. This is a core commercial objective.\n- **Exclusive Vending Rights  Kiosks**:\nGaining exclusive vending rights and installing 20 branded kiosks are actions that directly drive sales and increase market share within a specific, high-traffic geography. This is a primary commercial objective.\n- **Branded Signage**:\nIntegrating brand signage into park fixtures, including playgrounds, serves to normalize the brand and create positive associations, especially among children and families. This is a marketing objective. The 15,000,000 brand impressions are a direct measure of the success of this objective.\n- **Advisory Council Seat**:\nA seat on the Parks and Wellness Advisory Council provides direct access to policymakers. This allows the company to influence future policies, regulations, and public-private partnerships in its favor, which is a strategic commercial objective.\n\nSince the action's conditions are replete with elements that align with SodaCo's commercial objectives of marketing, sales, and policy influence, the criterion for **Intent ($I$) is met**.\n\n**2. Analysis of Materiality ($M$)**\nThe definition requires non-trivial changes in exposures or behaviors, distinct from the donation's dollar value (\\$2,000,000).\n- **Change in Exposure**: The scenario reports $X=15,000,000$ additional local brand impressions. This is a large, measurable, and therefore non-trivial increase in marketing exposure. The addition of 20 kiosks and pervasive signage represents a material change to the park environment.\n- **Change in Behavior**: The scenario reports two key behavioral changes:\n    1. An 8% year-over-year increase in SSB unit sales within a $1\\,\\mathrm{km}$ radius of the parks. This is a non-trivial, measurable change in purchasing behavior.\n    2. An increase of 2 SSB servings per week among local adolescents. This is a direct, non-trivial change in consumption behavior.\n\nThe evidence shows that the action materially altered both marketing exposure and health-related behaviors. Therefore, the criterion for **Materiality ($M$) is met**.\n\n**3. Analysis of Plausible Health Impact Pathways ($P$)**\nThe definition requires a causally coherent chain from the action to health outcomes via recognized mechanisms. The problem notes two such chains.\n- **Pathway 1 (Negative Health Impact)**: `SodaCo's Action` $\\rightarrow$ `Increased SSB Availability  Marketing Exposure` $\\rightarrow$ `Increased SSB Consumption` (evidenced by sales and adolescent survey data) $\\rightarrow$ `Increased Risk of Obesity and Type 2 Diabetes` (established scientific fact). This is a coherent and evidenced causal pathway.\n- **Pathway 2 (Positive Health Impact)**: `SodaCo's Action (Park Renovation)` $\\rightarrow$ `Improved Park Environment` $\\rightarrow$ `Increased Physical Activity` (evidenced by observational and self-report data) $\\rightarrow$ `Reduced Cardiometabolic Risk` (established scientific fact). This is also a coherent causal pathway.\n\nThe core definition of commercial determinants of health is concerned with the *influence* of commercial actors on health. It does not require that this influence be exclusively negative or that the net effect is harmful. The existence of at least one plausible, material pathway through which the commercial actor's practices influence health is sufficient for classification. Here, a clear pathway from the commercial practices (marketing, sales) to adverse health risks exists and is supported by data.\n\nTherefore, the criterion for **Plausible Health Impact Pathways ($P$) is met**.\n\n**Conclusion**\nAll three criteria—Intent ($I$), Materiality ($M$), and Plausible Pathways ($P$)—are satisfied according to the provided definitions and scenario data. Consequently, SodaCo's donation constitutes a commercial determinant of health.\n\n### Option-by-Option Analysis\n\n**A. No; philanthropic donations cannot be commercial determinants of health because they are not direct product promotion.**\nThis statement is factually incorrect based on the problem's own definitions. Definition (ii) for intent explicitly anticipates actions \"framed as Corporate Social Responsibility (CSR)\". The definition of commercial determinants (i) is broad, including \"systems, practices, and pathways,\" which is not limited to direct promotion. The scenario is a textbook example of a practice that, while framed as philanthropy, serves commercial purposes.\n**Verdict: Incorrect.**\n\n**B. Yes; philanthropic donations qualify as commercial determinants of health when they are tied to branding, market access, or policy influence that materially shifts exposure and behavior through plausible pathways, as in this scenario.**\nThis statement accurately synthesizes the application of the $I, M, P$ framework. It correctly identifies that the philanthropic \"frame\" is irrelevant when the action is \"tied to branding, market access, or policy influence\" (satisfying criterion $I$), \"materially shifts exposure and behavior\" (satisfying criterion $M$), and does so \"through plausible pathways\" (satisfying criterion $P$). Our analysis confirms that this is precisely what occurs in the scenario.\n**Verdict: Correct.**\n\n**C. No; because park renovations increase physical activity, any harms from higher SSB consumption are offset, placing the donation outside the commercial determinants of health.**\nThis is a flawed argument. The boundary test is for classification, not for a net health impact assessment. The existence of a plausible pathway of influence from the commercial actor is what matters for the definition of a commercial determinant, not whether that influence is counteracted by other effects. A practice that influences health does not cease to be a determinant just because another, countervailing influence exists.\n**Verdict: Incorrect.**\n\n**D. It depends on explicit disclosure of intent; without a written admission of marketing or policy aims, intent cannot be inferred, so classification is indeterminate.**\nThis statement directly contradicts definition (ii), which explicitly states that intent is \"inferred from the alignment of an action with a firm’s commercial objectives\". It does not require admission. The provided scenario gives ample evidence (naming rights, vending rights, etc.) from which to infer intent.\n**Verdict: Incorrect.**\n\n**E. Yes only if the donation exceeds \\$10,000,000; smaller donations are immaterial and thus outside the commercial determinants of health.**\nThis statement contradicts definition (iii) for materiality, which explicitly decouples materiality from the \"dollar magnitude of the donation\". Materiality is judged by the impact on exposures and behaviors, which the scenario demonstrates were non-trivial despite the donation being \\$2,000,000, an amount less than the arbitrary \\$10,000,000 threshold proposed in the option.\n**Verdict: Incorrect.**",
            "answer": "$$\\boxed{B}$$"
        },
        {
            "introduction": "After identifying a harmful commercial influence and implementing a policy to counteract it, how do we know if the policy actually worked? Simply comparing outcomes before and after the intervention can be misleading, as other trends might confound the results. This final practice introduces the difference-in-differences (DiD) method, a powerful and widely used technique in policy evaluation that allows us to better isolate the causal effect of an intervention by comparing the change in a treated group to the change in a control group .",
            "id": "4582672",
            "problem": "A municipal coalition concerned with the commercial determinants of health initiates a preventive policy: a ban on retail promotion and outdoor advertising of sugar-sweetened beverages (SSB) in selected cities. Let $T$ denote the set of treated cities that implemented the ban and $C$ denote the set of control cities that did not. Average per-capita daily SSB consumption is measured before and after the policy. The observed group-time averages are $\\bar{C}_{pre}^{T} = 10$, $\\bar{C}_{post}^{T} = 8$, $\\bar{C}_{pre}^{C} = 9$, and $\\bar{C}_{post}^{C} = 9$, where $\\bar{C}$ denotes average consumption in servings per capita per day, the subscript indicates time ($pre$ for pre-ban and $post$ for post-ban), and the superscript indicates group ($T$ for treated, $C$ for control).\n\nStarting from the core causal definition that a treatment effect is the difference between the treated outcome and the counterfactual untreated outcome, and using the well-tested difference-in-differences logic under the parallel trends assumption to construct a counterfactual for the treated group, compute the difference-in-differences estimate of the ban’s effect on consumption. Express your final answer in servings per capita per day. Provide a single numeric value; no derivations are required in the final answer.",
            "solution": "The fundamental base for this evaluation is the causal estimand of an average treatment effect, defined as the difference between the expected outcome under treatment and the expected counterfactual outcome that would have occurred without treatment. Let $Y_{g,t}$ denote the average outcome for group $g \\in \\{T,C\\}$ at time $t \\in \\{pre,post\\}$, and let $Y_{g,t}(d)$ denote the potential outcome for group $g$ at time $t$ under treatment status $d \\in \\{0,1\\}$, where $d=1$ indicates exposure to the ban and $d=0$ indicates no exposure. The target effect for the treated group at the post-ban time is\n$$\n\\Delta \\equiv \\mathbb{E}\\big[Y_{T,post}(1)\\big] - \\mathbb{E}\\big[Y_{T,post}(0)\\big].\n$$\nWe observe $\\mathbb{E}\\big[Y_{T,post}(1)\\big]$ but not $\\mathbb{E}\\big[Y_{T,post}(0)\\big]$, the latter being the counterfactual outcome for treated cities had they not implemented the ban. Under the parallel trends assumption—a well-tested identifying condition in policy evaluation—the untreated change over time for treated cities equals the untreated change over time for control cities:\n$$\n\\mathbb{E}\\big[Y_{T,post}(0) - Y_{T,pre}(0)\\big] = \\mathbb{E}\\big[Y_{C,post}(0) - Y_{C,pre}(0)\\big].\n$$\nBecause control cities are untreated at both times, we observe $\\mathbb{E}\\big[Y_{C,post}(0)\\big] = \\mathbb{E}\\big[Y_{C,post}\\big]$ and $\\mathbb{E}\\big[Y_{C,pre}(0)\\big] = \\mathbb{E}\\big[Y_{C,pre}\\big]$. Rearranging, we obtain a consistent estimator for the average treatment effect as the difference-in-differences:\n$$\n\\widehat{\\Delta} = \\big(\\mathbb{E}[Y_{T,post}] - \\mathbb{E}[Y_{T,pre}]\\big) - \\big(\\mathbb{E}[Y_{C,post}] - \\mathbb{E}[Y_{C,pre}]\\big).\n$$\nIn this application, $Y$ is per-capita daily SSB consumption (servings per capita per day), and the group-time averages are given by $\\bar{C}_{pre}^{T} = 10$, $\\bar{C}_{post}^{T} = 8$, $\\bar{C}_{pre}^{C} = 9$, and $\\bar{C}_{post}^{C} = 9$. Substituting the observed averages into the estimator:\n$$\n\\widehat{\\Delta} = \\big(8 - 10\\big) - \\big(9 - 9\\big) = (-2) - (0) = -2.\n$$\nThe sign indicates the direction of the effect: a negative value corresponds to a reduction in consumption attributable to the ban under the maintained assumptions. The magnitude is $-2$ servings per capita per day.",
            "answer": "$$\\boxed{-2}$$"
        }
    ]
}